New Insights Into Metabolic Markers for Drug-Resistant Epilepsy
Researchers studied drug-resistant epilepsy (DRE), which affects people who do not respond to standard seizure medications.
Discover the latest findings in recent epilepsy research, where we break down complex studies into clear insights. Stay informed about cutting-edge breakthroughs, evolving theories, and advancements shaping our understanding of epilepsy.
Researchers studied drug-resistant epilepsy (DRE), which affects people who do not respond to standard seizure medications.
Researchers studied the effects of valproate, a medication used to treat epilepsy and bipolar disorder, on infertility in men.
This study looked at the long-term outcomes of 236 patients with a specific type of autoimmune encephalitis called anti-LGI1 encephalitis, which often causes seizures and cognitive issues.
This study looked at adults who were newly diagnosed with a type of epilepsy called genetic generalized epilepsy (GGE).
A study called the MonoPER study looked at how effective and tolerable the medication Perampanel (PER) is when used alone to treat adults with focal or idiopathic generalized epilepsy.
A recent study looked at two different treatments for people with epilepsy caused by a brain condition called focal cortical dysplasia (FCD) that shows up on MRI scans.
Researchers studied the effectiveness of five newer anti-seizure medications (ASMs) in treating Lennox-Gastaut syndrome (LGS), a severe form of epilepsy that begins in childhood and is often resistant to treatment.
This study looked at the long-term quality of life for people who survived a severe type of epilepsy called new onset refractory status epilepticus (NORSE), including a specific form known as febrile infection-related epilepsy syndrome (FIRES).
This study looked at how often and when side effects occurred in adult Asian patients with focal-onset seizures while they were treated with brivaracetam (BRV).